Sutro Biopharma Inc (STRO)

Sutro Biopharma Financial Statements

Sutro Biopharma Financial Overview

Sutro Biopharma's market cap is currently ―. The company's EPS TTM is $-2.47; its P/E ratio is -1.76; Sutro Biopharma is scheduled to report earnings on August 10, 2022, and the estimated EPS forecast is $-0.66. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Dec 21Sep 21Jun 21Mar 21
Income Statement
Total Revenue$ 5.90M$ 10.65M$ 8.52M$ 28.05M$ 14.66M
Gross Profit$ ―$ ―$ ―$ ―$ ―
EBIT$ -38.45M$ -37.51M$ -30.08M$ -5.30M$ -29.50M
EBITDA$ -37.13M$ -36.20M$ -28.96M$ -4.18M$ -28.21M
Net Income Common Stockholders$ -39.11M$ -38.13M$ -30.90M$ -6.15M$ -30.36M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 197.94M$ 209.15M$ 229.70M$ 251.23M$ 258.70M
Total Assets$ 303.68M$ 341.41M$ 371.47M$ 359.79M$ 358.53M
Total Debt$ 24.82M$ 32.11M$ 34.96M$ 38.26M$ 44.40M
Net Debt$ -173.12M$ -177.04M$ -194.74M$ -212.97M$ -214.31M
Total Liabilities$ 83.30M$ 88.84M$ 87.89M$ 52.29M$ 51.19M
Stockholders Equity$ 220.37M$ 244.12M$ 252.56M$ 283.58M$ 307.34M
Cash Flow
Free Cash Flow$ -36.81M$ -24.12M$ -29.40M$ -10.68M$ -32.81M
Operating Cash Flow$ -35.26M$ -21.58M$ -24.41M$ -5.26M$ -30.43M
Investing Cash Flow$ 32.98M$ 20.78M$ -2.24M$ 5.88M$ -121.73M
Financing Cash Flow$ 760.00K$ 506.00K$ 963.00K$ -39.00K$ 1.83M
Currency in USD

Sutro Biopharma Earnings and Revenue History

Sutro Biopharma Debt to Assets

Sutro Biopharma Cash Flow

Sutro Biopharma Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis